WordNet

lack of success; "he felt that his entire life had been a failure"; "that year there was a crop failure"
loss of ability to function normally; "kidney failure"
an act that fails; "his failure to pass the test"
an unexpected omission; "he resented my failure to return his call"; "the mechanics failure to check the brakes"
a person with a record of failing; someone who loses consistently (同)loser, nonstarter, unsuccessful person
an event that does not accomplish its intended purpose; "the surprise party was a complete failure"
of or involving the ovaries; "ovarian cancer"

PrepTutorEJDIC

〈U〉(…における)『失敗』,不成功《+『in』+『名』(do『ing』)》 / 〈C〉失敗者,落後者;失敗した企て,不できなもの / 〈U〉〈C〉怠慢,不履行 / 〈U〉〈C〉(…の)不足,欠乏《+『of』+『名』》 / 〈U〉〈C〉(…の)破産《+『of』+『名』》 / 〈U〉(…の)『衰弱』,減退《+『in』(『of』+『名』》
卵巣の / 子房(しぼう)の

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 自発性早期卵巣障害（早期卵巣機能不全）の臨床症状および評価 clinical manifestations and evaluation of spontaneous primary ovarian insufficiency premature ovarian failure
2. 原発性早期卵巣障害（早期卵巣機能不全）の管理 management of spontaneous primary ovarian insufficiency premature ovarian failure
3. 原発性早期卵巣障害（早期卵巣機能不全）の病因と原因 pathogenesis and causes of spontaneous primary ovarian insufficiency premature ovarian failure
4. 自己免疫性卵巣機能不全の病因、診断、および治療 pathogenesis diagnosis and treatment of autoimmune ovarian failure
5. 抗癌剤および放射線療法による卵巣機能不全 ovarian failure due to anticancer drugs and radiation

LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study.

Recchia F1, Necozione S2, Bratta M3, Rosselli M4, Guerriero G3, Rea S3.
International journal of oncology.Int J Oncol.2015 Mar;46(3):1354-60. doi: 10.3892/ijo.2014.2811. Epub 2014 Dec 30.
To prevent premature ovarian failure (POF), high-risk, premenopausal women with early breast cancer were given a luteinizing-hormone releasing hormone (LH-RH) analogue during adjuvant chemotherapy. After an adriamycin-based regimen, patients received radiation therapy concomitant with cyclophosphami
PMID 25572674

Problems during the Long-Term Follow-Up after Surgery for Pediatric Solid Malignancies.

Oue T1, Miyoshi Y2, Hashii Y2, Uehara S1, Ueno T1, Nara K1, Usui N1, Ozono K2.
European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie.Eur J Pediatr Surg.2015 Feb;25(1):123-7. doi: 10.1055/s-0034-1386639. Epub 2014 Aug 21.
Introduction With the recent improvements in the prognosis of pediatric malignancies, the number of patients surviving long-term after surgery has been increasing. Therefore, the late effects of cancer treatments are important issues. In this study, we analyzed the problems associated with the tre
PMID 25144353

Tumor heterogeneity has important consequences for personalized medicine in ovarian cancer.

Gui T1, Cao D1, Yang J1, Shen K2.
Histology and histopathology.Histol Histopathol.2015 Feb;30(2):173-181. Epub 2014 Jul 24.
Most patients with ovarian cancers relapse, and treatment failure has often been attributed to chemoresistance in tumor cells. Emerging evidence indicates that tumor heterogeneity may play an equally important role. Although the idea of tumor heterogeneity is not new, little attention has been focus
PMID 25058000

Differential Apoptotic and Proliferative Activities of Wild-type FOXL2 and Blepharophimosis-ptosis-epicanthus Inversus Syndrome (BPES)-associated Mutant FOXL2 Proteins